| 000 | 01680 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513212506.0 | ||
| 264 | 0 | _c20000626 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.2000.02016.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMantovani, L | |
| 245 | 0 | 0 |
_aTreatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cMay 2000 |
||
| 300 |
_a367-75 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnemia _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aErythrocyte Count |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xblood |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLentini, G | |
| 700 | 1 | _aHentschel, B | |
| 700 | 1 | _aWickramanayake, P D | |
| 700 | 1 | _aLoeffler, M | |
| 700 | 1 | _aDiehl, V | |
| 700 | 1 | _aTesch, H | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 109 _gno. 2 _gp. 367-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.2000.02016.x _zAvailable from publisher's website |
| 999 |
_c10799954 _d10799954 |
||